Weight-loss medications commonly known as “fat jabs”—such as Wegovy, copyright, and Mounjaro—are now showing potential as powerful cancer-prevention tools, according to a new study by researchers in Israel. These drugs, classified as GLP-1 receptor agonists, were initially developed to treat diabetes and later gained popularity for their effectiveness in aiding weight loss. However, t... https://healthcare360magazine.com/weight-loss-medications/